MELISSA PATTEE: Open Payments
NPI 1649504291 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,699 in 117 payments from 14 companies in 2025. Trend: 2023 $2,115 · 2024 $2,179 · 2025 $2,699
Food & beverage: $2,600Education: $99
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 5 | $448 |
| Incyte Corporation | 15 | $339 |
| GENZYME CORPORATION | 8 | $319 |
| Janssen Biotech, Inc. | 6 | $305 |
| ABBVIE INC. | 16 | $241 |
| Novartis Pharmaceuticals Corporation | 27 | $196 |
| Galderma Laboratories, L.P. | 11 | $177 |
| Regeneron Healthcare Solutions, Inc. | 7 | $166 |
| Lilly USA, LLC | 6 | $150 |
| UCB, Inc. | 5 | $112 |
Products named: Zoryve, DUPIXENT, OPZELURA, TREMFYA, NEMLUVIO, SKYRIZI, TALTZ, Bimzelx.
Industry payments across CA — which companies pay providers there.
